Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technaid is a Spanish rehabilitation and biomechanics technology company that develops research-focused medical and human-motion analysis equipment. Founded in 2004 as a spin-off of the Spanish National Research Council's bioengineering group, the company commercializes inertial motion-capture systems, IMU sensors, motion-analysis software, and lower-limb robotic exoskeletons for neurorehabilitation and gait research. Its core product families include the Tech-MCS motion capture system, Tech IMU sensors, Exo-H3 robotic exoskeleton, and Robotic Ankle H3. Technaid primarily serves laboratories, universities, and research groups working in rehabilitation, biomechanics, neuroscience, and sports science rather than operating as a drug-development biotech. The company appears to be an active private business headquartered near Madrid, Spain, with a strong orientation toward translational R&D and European research collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technaid.